Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach.

The M3 from the Japanese cohort wholly covered all the genes involved M11 from the TCGA cohort, which is highly significant overlap (n=41, hypergeometric test, P < 1.1e-16, Figure 2 g).

also in 132,142 other papers